- OVERVIEW
- PRODUCTS
- Casting & Splinting
- Hand Hygiene
- Patient Monitoring
- Securement and Immobilization
- Skin Care
- Wound Care
- Sterilization & Monitoring
- Surgical Solutions
- Vascular Access
- View all
- CONDITIONS
- Bloodstream Infections
- Incision Management
- Surgical Site Infections
- Incontinence-Associated Dermatitis
- Pressure Injury Prevention
- Wound Care
- EDUCATION
- SUPPORT
Our apologies...
An error has occurred while submitting. Please try again later...
Thank you!
Your form was submitted successfully
3M™ Cavilon™ Advanced Skin Protectant has a formulation unlike any other skin protectant or moisture barrier currently available, allowing you to manage damaged skin or protect at-risk skin like never before. But what makes it so different from traditional skin barrier creams?
-
Unique, elastomeric polymer3M’s polymer forms a coating with the ability to elongate or conform, avoiding the cracking that can be common with other moisture barriers. This assures greater skin barrier integrity and durability and protection against challenging irritants, such as liquid stool and gastric fluids.
-
Revolutionary polymer-cyanoacrylate systemUnlike skin protectant barrier products that cannot reliably attach to underlying skin, 3M’s polymer-cyanoacrylate enables attachment to wet, weepy, damaged skin.¹ Once on the skin, 3M™ Cavilon™ Advanced Skin Protectant creates an environment that repels irritants and supports patient healing and comfort.
-
Non-stinging solventThe polymer-cyanoacrylate system is delivered onto the skin by a non-stinging solvent in a single-use applicator that reduces the potential for cross-contamination. Plus, 3M™ Cavilon™ Advanced Skin Protectant doesn’t require removal, making wear easier for patients and easier for clinicians.
Skin Protection Powerful Enough to Change the Standard of Care
A clear improvement on traditional treatment options for damaged or at-risk skin, 3M™ Cavilon™ Advanced Skin Protectant delivers ultimate skin protection and prevention – even under the most challenging circumstances.
-
Dec 1, 1901 -
Dec 1, 1901 -
Dec 1, 1901 -
Dec 1, 1901 -
Dec 1, 1901 -
*3M™ Cavilon™ Advanced Skin Protectant is not an analgesicDec 1, 1901
The Impact is Clear
Healthcare-acquired skin damage represents negative clinical outcomes resulting in potential complications such as infection, pain and suffering, and a poor patient experience. In addition, skin damage increases the work and cost of care. Learn why 3M™ Cavilon™ Advanced Skin Protectant is a clear improvement over traditional treatment options.
-
See the Estimated Cost SavingsBased on six incontinence episodes per day³, two nurses at 3.9 hours/week at $33.23/hour⁴ each; application/cleansing time of 45 sec/2 min ⁵, ¹; three applications per week.
-
See Significant ImprovementStudy showed IAD pain decreased in 100% of patients reporting pain.¹*
*3M™ Cavilon™ Advanced Skin Protectant is not an analgesic.
-
See the Clinical EvidenceExplore the impact of 3M™ Cavilon™ Advanced Skin Protectant as detailed in numerous clinical publications including Advances in Wound Care.
Effect on Microbial Growth of a New Skin Protectant Formulation (PDF, 294.28 KB)
The many uses of 3M™ Cavilon™ Advanced Skin Protectant
When you need to manage damaged or broken skin and protect at-risk skin, choose 3M™ Cavilon™ Advanced Skin Protectant. Use the slider below to learn more about the types of healthcare-acquired skin damage that you can help protect your patients against.
-
Incontinence-Associated DermatitisDec 1, 1901Severe inflammation caused by liquid stool, mixed incontinence or urine, which can lead to destruction of the epidermis.
-
Peristomal Skin DamageDec 1, 1901Problem stomas, poor stoma location and high-volume output, especially that of liquid stool, can contribute to skin injury that can rapidly progress to erosion.
-
Periwound Skin DamageDec 1, 1901This type of skin damage is often associated with wounds that produce large quantities of drainage, such as venous ulcers or infected wounds.
-
Pressure Ulcer/Injury (PU/I)Dec 1, 1901Localized damage to the skin and underlying soft tissue, usually over a bony prominence or related to a medical or other device. Moisture, friction and shear are accepted risk factors for pressure ulcer/ injury development.
-
Medical Adhesive-Related Skin Injury (MARSI)Dec 1, 1901Skin damage, such as stripping or maceration, related to adhesive product use.
Simplifying Your Skin Integrity Needs
Finding the optimal solution for your skin integrity needs can often be confusing. 3M can help you protect patient skin like no other partner can, because we apply ingenuity to our innovations. We’re here to help guide the product selection process based on your needs and clinical challenges.
Transforming Outcomes
Explore how science and innovation are transforming the healthcare industry.
Resources
-
Discover how protecting at-risk patients from IAD and its associated complications is easier than ever before, and why 3M™ Cavilon™ Advanced Skin Protectant is one of the best skin barrier creams for incontinence. -
Incontinence-Associated Dermatitis Identification GuideLearn what to look for when caring for patients at risk for IAD — and how to differentiate Incontinence-Associated Dermatitis from pressure ulcers or injuries.
-
Understanding and Managing Incontinence-Associated DermatitisIAD is a challenge in acute and long-term care settings. Learn more about the importance of maintaining the skin integrity of patients at risk for IAD.
References
- Brennan, Mary R.; Milne, Catherine T.; Agrell-Kann, Marie; Ekholm, Bruce P. Clinical Evaluation of a Skin Protectant for the Management of Incontinence Associated Dermatitis: An Open-Label, Nonrandomized, Prospective Study. J of Wound, Ostomy & Continence Nursing. 2017. 44(2):172-180.
- 3M data on file. EM-05-01 3924.
- Bliss DZ, Zehrer C, Savik K, Smith G, Hedblom E. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence. J WOCN 2007;34(2):143-52.
- Bureau of Labor Statistics. Occupational Employment Statistics for 31-1014 Nursing Assistant. (May 2015). Accessed on 5/18/2016 http://www.bls.gov/oes current/oes311014.htm
- Heidegger CP; Graf S; Perneger T; Genton L; Oshima T; Pichard C. The burden of diarrhea in the intensive care unit (ICU-BD). A survey and observational study of the caregivers’ opinions and workload. Int J Nurs Stud. 2016 Jul;59:163-8
